HER2-positive Breast Cancer Clinical Trials in Hangzhou
2 recruitingHangzhou, China
Showing 1–2 of 2 trials
Recruiting
A Study to Assess the Effectiveness of Trastuzumab Deruxtecan in Chinese Breast Cancer Patients (REFRESH)
Breast CancerHER2-low Breast CancerHER2-positive Breast Cancer+1 more
Daiichi Sankyo800 enrolled54 locationsNCT06210776
Recruiting
Phase 2
Neoadjuvant Chemotherapy Plus Pyrotinib and Trastuzumab for HER2-positive Breast Cancer (NEOTORCH-BREAST05)
Neoadjuvant TherapyHER2-positive Breast CancerPyrotinib
First Affiliated Hospital of Zhejiang University33 enrolled1 locationNCT06832904